Skip to main content
Caplight Logo









Chitozan Health

Chitozan Health

Private
Summerville, South CarolinaHealthcare & Life Scienceshttps://chitozanhealth.com

Last Round

Grant

Feb 1, 2024

Total Funding Raised

$254,157

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Chitozan Health is a biotechnology company that develops and manufactures a patented antimicrobial technology based on silver chitosan for use in medical devices, textiles, and wound care.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

antimicrobial technologysilver-chitosaninfection controlantimicrobial textileswound carebiotechadvanced materialsbiofilm managementmedical device coatingshospital-acquired infectionsHAIantimicrobial resistanceAMRsmart textilesbiotech IP

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Chitozan Health Comparables

Compare Chitozan Health with similar companies based on industry and business-model similarity.

Chitozan Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AG21 Health Sciences, LLC
87%
Nolla Antimicrobial Oy
78%
PurThread Technologies
77%

Chitozan Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 1, 2024
GrantJul 12, 2022

Chitozan Health Investors

Notable investors and investment history

Chitozan Health investors
InvestorRounds
National Institute of Allergy and Infectious DiseasesGrant
NIH RADxGrant
Suzano VenturesAccelerator
Cycle MomentumAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 106% MoM.

  • Feb 1, 2024

    $100K raised in grant round.

Chitozan Health Filings

Explore SEC and related filing metadata, where available.

Chitozan Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Chitozan Health's valuation, stock price, and market status.

Is Chitozan Health a public or private company?

Chitozan Health is a private company.

What is the current stock price of Chitozan Health?

Chitozan Health is a private company, so its shares have no public market price. Caplight tracks Chitozan Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Chitozan Health worth (valuation)?

Valuation information for Chitozan Health is not publicly available.

Can I buy Chitozan Health stock?

Chitozan Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Chitozan Health's last funding round?

Chitozan Health's most recent funding round was Grant on February 1, 2024.

Who are the main investors in Chitozan Health?

Key investors in Chitozan Health include National Institute of Allergy and Infectious Diseases.

Will Chitozan Health IPO soon?

No public IPO plans have been announced for Chitozan Health.

How can I track Chitozan Health secondary market activity?

Caplight tracks bids, offers, and trades in Chitozan Health's shares on secondary markets.

Firmographic Details

HeadquartersSummerville, South Carolina
Employee Range1
Year Founded2018
Last FundingFeb 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?